An investor suing property investment group Aviation 3030 can’t avoid payment of half a million dollars in security for litigation costs because of a parallel enforcement action by the corporate regulator, a judge has ruled.
Consumer goods giant Reckitt Benckiser has been permanently barred from displaying select ads for its Strepfen throat lozenges, as the Federal Court dismissed proceedings filed by rival iNova Pharmaceuticals.
Mobile garbage bin manufacturer Mastec Australia can access documents from a group of city councils and waste management firms to calculate damage it suffered from rival Trident Plastics unlawful copying of its wheelie bin design.
A lawyer for Geoffrey Rush told a judge Wednesday that the Sydney Theatre Company did not commence an investigation into allegations of sexual harassment by Geoffrey Rush until 18 months after an actress made the complaint during a “off-the-record” conversation in a bar.
An IVF clinic that pioneered the use of artificial intelligence for embryo selection has sued a rival clinic for allegedly copying an advertising campaign featuring the slogan “more chubby cheeks”.
Vocational trainer Empower Institute engaged in unconscionable conduct by “duping” disadvantaged consumers into enrolling in courses they couldn’t afford with the promise of free laptops and cash, a judge ruled Wednesday.
Liquidators for failed engineering services company Hastie Group have a fight on their hands over tens of millions of dollars in unpaid invoices from construction companies, with major builders claiming not only that they don’t have to pay, but that the bills aren’t payable.
Geoffrey Rush’s legal team plans to question his King Lear co-star over a break-up with her partner, arguing the actress at the centre of a defamation case might have been distressed by the relationship split, not by any allegedly inappropriate behaviour by the Oscar-winning actor.
A judge has granted Cargill Australia’s request to call a King & Wood Mallesons solicitor that represented Viterra as a witness in the epic trial over the $420 million sale of Viterra’s Joe White business to Cargill in 2013.
The Full Federal Court has shot down Reckitt Benckiser’s appeal of a ruling that it misled consumers with claims that its Nurofen is a more effective pain killer than rival GlaxoSmithKline’s Panadol.